The World Health Organisation (WHO) has recognized Suriname among a total of eight countries that are implementing measures in harmony with WHO's Framework Convention on Tobacco Control (FCTC) to safeguard their citizens from newer tobacco products.
Together with the recent prohibition of marketing and usage of e-cigarettes in Venezuela, 21 nations in the Americas now regulate electronic nicotine delivery systems (ENDS) such as vapes and e-cigarettes.
Dr. Anselm Hennis of the Pan American Health Organization highlighted the importance of the move in Venezuela for the nation and the region. He expressed hope other nations would follow suit due to the addictive, harmful nature of these products, which are heavily marketed towards young individuals.
Argentina, Brazil, Mexico, Nicaragua, Panama, Suriname, Uruguay, and Venezuela are the latest countries to join the initiative, either partially or fully implementing one or more regulatory measures or outright prohibiting the sale of ENDS.
Meanwhile, 14 countries in the Americas, including in the Caribbean, still have no regulations controlling these products.
The most recent action from the Venezuelan Ministry of Popular Power for Health, which follows last year's prohibition of vape sales to minors, bans the manufacture, supply, advertising, and related activities of ENDS and electronic non-nicotine delivery systems.
PAHO/WHO recommends that governments apply regulations aligned with FCTC's guidelines and its decisions, such as banning any marketing or sale of ENDS, restricting their use in public places, prohibiting their promotion, applying taxes, and other similar regulations that are applied to conventional tobacco products.
Tobacco claims the lives of one million people each year in the Americas and 11.3% of adolescents between 13 and 15 years of age in the region use tobacco, surpassing the global average of 10.3%.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
